Effects of COVID-19 on Cognition and Brain Health

Overview

Journal Trends Cogn Sci

Date 2023 Sep 1

PMID 37657964

Authors

Sijia Zhao

Sofia Toniolo

Adam Hampshire

Masud Husain

Affiliations

Soon will be listed here.

Abstract

COVID-19 is associated with a range of neurological, cognitive, and mental health symptoms both acutely and chronically that can persist for many months after infection in people with long-COVID syndrome. Investigations of cognitive function and neuroimaging have begun to elucidate the nature of some of these symptoms. They reveal that, although cognitive deficits may be related to brain imaging abnormalities in some people, symptoms can also occur in the absence of objective cognitive deficits or neuroimaging changes. Furthermore, cognitive impairment may be detected even in asymptomatic individuals. We consider the evidence regarding symptoms, cognitive deficits, and neuroimaging, as well as their possible underlying mechanisms.

Citing Articles

Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes.

Diez-Cirarda M, Yus-Fuertes M, Delgado-Alonso C, Gil-Martinez L, Jimenez-Garcia C, Gil-Moreno M Mol Psychiatry. 2025; .

PMID: 39815057 DOI: 10.1038/s41380-024-02886-x.

The population based cognitive testing in subjects with SARS-CoV-2 (POPCOV2) study: longitudinal investigation of remote cognitive and fatigue screening in PCR-positive cases and negative controls.

von Etzdorf A, Harzen M, Heinrichs H, Seifert H, Groiss S, Balloff C Front Hum Neurosci. 2024; 18:1468204.

PMID: 39677403 PMC: 11638161. DOI: 10.3389/fnhum.2024.1468204.

Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis.

Shan D, Wang C, Crawford T, Holland C BMC Geriatr. 2024; 24(1):940.

PMID: 39674870 PMC: 11646349. DOI: 10.1186/s12877-024-05538-5.

Long COVID: A Comprehensive Overview of the Signs and Symptoms across Multiple Organ Systems.

Merhavy Z, Junor T, Gonzalez A, De Filippis S, Oveisitork S, Rivera E Korean J Fam Med. 2024; 45(6):305-316.

PMID: 39600184 PMC: 11605154. DOI: 10.4082/kjfm.24.0085.

Characterization of Change in Cognition Before and After COVID-19 Infection in Essential Workers at Midlife.

Sekendiz Z, Morozova O, Carr M, Fontana A, Mehta N, Ali A Am J Med Open. 2024; 12:100076.

PMID: 39498311 PMC: 11533481. DOI: 10.1016/j.ajmo.2024.100076.

References

Danesh V, Arroliga A, Bourgeois J, Boehm L, McNeal M, Widmer A . Symptom Clusters Seen in Adult COVID-19 Recovery Clinic Care Seekers. J Gen Intern Med. 2022; 38(2):442-449. PMC: 9663188. DOI: 10.1007/s11606-022-07908-4. View

Canas L, Molteni E, Deng J, Sudre C, Murray B, Kerfoot E . Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Lancet Digit Health. 2023; 5(7):e421-e434. PMC: 10187990. DOI: 10.1016/S2589-7500(23)00056-0. View

Benedetti F, Palladini M, Paolini M, Melloni E, Vai B, De Lorenzo R . Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study. Brain Behav Immun Health. 2021; 18:100387. PMC: 8562046. DOI: 10.1016/j.bbih.2021.100387. View

Cysique L, Jakabek D, Bracken S, Allen-Davidian Y, Heng B, Chow S . The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC. Ann Clin Transl Neurol. 2023; 10(8):1338-1352. PMC: 10424655. DOI: 10.1002/acn3.51825. View

Frontera J, Boutajangout A, Masurkar A, Betensky R, Ge Y, Vedvyas A . Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia. Alzheimers Dement. 2022; 18(5):899-910. PMC: 9011610. DOI: 10.1002/alz.12556. View

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Caroli A, Capelli S, Napolitano A, Cabrini G, Arrigoni A, Pezzetti G . Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations. Neuroimage Clin. 2023; 37:103338. PMC: 9883079. DOI: 10.1016/j.nicl.2023.103338. View

Wang Q, Davis P, Gurney M, Xu R . COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021; 17(8):1297-1306. PMC: 8014535. DOI: 10.1002/alz.12296. View

Najjar S, Najjar A, Chong D, Pramanik B, Kirsch C, Kuzniecky R . Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020; 17(1):231. PMC: 7406702. DOI: 10.1186/s12974-020-01896-0. View

10.

Loo J, Spittle D, Newnham M . COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021; 76(4):412-420. DOI: 10.1136/thoraxjnl-2020-216243. View

11.

Liu Y, Chen Y, Wang Q, Wang L, Jiang L, Yang Y . One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 2022; 79(5):509-517. PMC: 8905512. DOI: 10.1001/jamaneurol.2022.0461. View

12.

Brown L, Ballentine E, Zhu Y, McGinley E, Pezzin L, Abramoff B . The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection. Brain Behav Immun Health. 2022; 22:100460. PMC: 8983478. DOI: 10.1016/j.bbih.2022.100460. View

13.

Zhao S, Shibata K, Hellyer P, Trender W, Manohar S, Hampshire A . Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun. 2022; 4(1):fcab295. PMC: 8807287. DOI: 10.1093/braincomms/fcab295. View

14.

Morand A, Campion J, Lepine A, Bosdure E, Luciani L, Cammilleri S . Similar patterns of [F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur J Nucl Med Mol Imaging. 2021; 49(3):913-920. PMC: 8376118. DOI: 10.1007/s00259-021-05528-4. View

15.

Taquet M, Geddes J, Husain M, Luciano S, Harrison P . 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5):416-427. PMC: 8023694. DOI: 10.1016/S2215-0366(21)00084-5. View

16.

Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P . Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021; 48(10):3187-3197. PMC: 7937050. DOI: 10.1007/s00259-021-05294-3. View

17.

Pihlaja R, Kauhanen L, Ollila H, Tuulio-Henriksson A, Koskinen S, Tiainen M . Associations of subjective and objective cognitive functioning after COVID-19: A six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun Health. 2023; 27:100587. PMC: 9812472. DOI: 10.1016/j.bbih.2023.100587. View

18.

Rau A, Schroeter N, Blazhenets G, Dressing A, Walter L, Kellner E . Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain. 2022; 145(9):3203-3213. PMC: 9214163. DOI: 10.1093/brain/awac045. View

19.

Toniolo S, Di Lorenzo F, Scarioni M, Frederiksen K, Nobili F . Is the Frontal Lobe the Primary Target of SARS-CoV-2?. J Alzheimers Dis. 2021; 81(1):75-81. DOI: 10.3233/JAD-210008. View

20.

Callard F, Perego E . How and why patients made Long Covid. Soc Sci Med. 2020; 268:113426. PMC: 7539940. DOI: 10.1016/j.socscimed.2020.113426. View